Vimarsana
Biggest News Aggregation in the World

Chan Chiu News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Chan Chiu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Chan Chiu Today - Breaking & Trending Today

Click Therapeutics Accelerates Expansion into Obesity and Cardiometabolic Disease With Acquisition of the Assets of Better Therapeutics, Inc. - Vimarsana News

Click Therapeutics Accelerates Expansion into Obesity and Cardiometabolic Disease With Acquisition of the Assets of Better Therapeutics, Inc.

Click Therapeutics, Inc. ("Click"), a leader in Digital Therapeuticstm as prescription medical treatments, today announced plans to accelerate its development initiatives in obesity and cardiometabolic disease through the acquisition of the assets of...

Click Therapeutics picks up Better's app assets in diabetes, obesity - Vimarsana News

Click Therapeutics picks up Better's app assets in diabetes, obesity

Click Therapeutics will obtain assets from the recently defunct Better Therapeutics, which began winding down operations in March.

Just Kitchen Holdings Corp.: JustKitchen Announces Proposed Going-Private Transaction - Vimarsana News

Just Kitchen Holdings Corp.: JustKitchen Announces Proposed Going-Private Transaction

Vancouver, British Columbia--(Newsfile Corp. - May 23, 2023) - Just Kitchen Holdings Corp. (TSXV: JK) (FSE: 68Z) ("JustKitchen" or the "Company"), an operator of ghost kitchens specializing in the development

SteadyMD, AmerisourceBergen partner for pharmacy telehealth and more digital health briefs - Vimarsana News

SteadyMD, AmerisourceBergen partner for pharmacy telehealth and more digital health briefs

Boehringer Ingelheim and Click Therapeutics initiate clinical trial on PDTx treatment for schizophrenia and Akili's EndeavorRx shows promise for adults with ADHD.

Ultromics receives Breakthrough Device Designation for AI cardiac amyloidosis tool and more digital health briefs - Vimarsana News

Ultromics receives Breakthrough Device Designation for AI cardiac amyloidosis tool and more digital health briefs

Click Therapeutics has begun a clinical trial for its episode migraine digital therapeutic, and Digital Diagnostics is offering its AI-backed diabetic retinopathy screening at select Labcorp locations.